A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Covid-19: Recovery trial set to lose funding as proposal to examine flu drugs is rejected
2022
The BMJ (British Medical Journal)
Preserved Fulltext
Funding for the UK's Randomised Evaluation of Covid-19 Therapy (Recovery) trial-which has been instrumental in finding cheap and effective covid-19 treatments-is to end in October, the trial's co-leads have said.
doi:10.1136/bmj.o1809
pmid:35853651
fatcat:gbsrlqnvwbdbpp6xlev2cbgc6a